Browse this section for recent public health research and data from India and the world.
The Non-Invasive Risk Assessment with Machine Intelligence (NIRAMAI) device is a no-contact early-stage breast cancer screening method. Breast cancer is currently the number one cancer among Indian females with a low survival rate. It's early detection and treatment are therefore imperative. This paper examines the efficacy of NIRAMAI with results obtained from the Government J. P. District Hospital in Bhopal, Madhya Pradesh. The results show that NIRAMAI is both accurate and cost-effective, the only limitation of this device is that it requires a stable internet connection. This paper, with essential information on NIRAMAI, provides detailed information on the device and its use. Can this be a possible addition to public health centers to aid breast cancer detection?
Mapping progress towards the SDG goal of reducing maternal mortality by 2030.
by WHO 75 min read